ArticleTherapeutic advances in hematology2020

BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib

Guang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.